These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7517058)

  • 1. [Use of high doses of aprotinin in cardiac surgery].
    Carrera A; Martínez MV; García-Guiral M; Herrero E; Peral A; Planas A
    Rev Esp Anestesiol Reanim; 1994; 41(1):13-9. PubMed ID: 7517058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reduction of postoperative blood loss and donor blood use in heart surgery with aprotinin: experience with various dosages].
    Carrel T; Bauer E; Garcia E; von Segesser L; Niederhäuser U; Schönbeck M; Laske A; Turina M
    Helv Chir Acta; 1991 Sep; 58(3):365-78. PubMed ID: 1722785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of low doses of aprotinin in heart surgery].
    Blanco E; Blanco J; Bóveda S; Sierra J; Rubio J; Durán D; Alvarez J
    Rev Esp Anestesiol Reanim; 1994; 41(3):168-71. PubMed ID: 7520188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose aprotinin to reduce blood loss in patients undergoing redo open heart surgery.
    Biagini A; Comite C; Russo V; Salerno ML; Gemignani R; Pardelli S; Baccellini M; Baroni M; Pugliese S; Maffei S
    Acta Anaesthesiol Belg; 1992; 43(3):181-6. PubMed ID: 1280394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion.
    Kristeller JL; Stahl RF; Roslund BP; Roke-Thomas M
    Pharmacotherapy; 2007 Jul; 27(7):988-94. PubMed ID: 17594204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose aprotinin in cardiac surgery: is high-dose high enough? An analysis of 8281 cardiac surgical patients treated with aprotinin.
    Dietrich W; Busley R; Kriner M
    Anesth Analg; 2006 Nov; 103(5):1074-81. PubMed ID: 17056935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aprotinin is not associated with postoperative renal impairment after primary coronary surgery.
    Lindvall G; Sartipy U; Ivert T; van der Linden J
    Ann Thorac Surg; 2008 Jul; 86(1):13-9. PubMed ID: 18573391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation.
    Verma YS; Chauhan S; Bisoi AK; Gharde P; Kiran U; Das SN
    Ann Card Anaesth; 2010; 13(2):110-5. PubMed ID: 20442540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of aprotinin as a blood conservation technique for adult deformity spinal surgery: a retrospective study.
    Tayyab NA; Mariller MM; Rivlin M; Berekashvili K; Bitan FD; Casden AM; Kuflik P; Neuwirth MG
    Spine (Phila Pa 1976); 2008 Jul; 33(16):1775-81. PubMed ID: 18628710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aprotinin (Antilysin Spofa)--its effect on decreasing hemorrhage in the postoperative period in hip arthroplasty].
    Cvachovec K; Sechovská H; Berousek J; Popelka S; Hladíková M
    Acta Chir Orthop Traumatol Cech; 2001; 68(5):311-4. PubMed ID: 11759474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of aprotinin in different doses and autologous blood transfusions in cardiac surgery.
    Gschossmann J; Pracki P; Struck E
    Cardiovasc Surg; 1994 Dec; 2(6):716-9. PubMed ID: 7532087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery.
    Jamieson WR; Dryden PJ; O'Connor JP; Sadeghi H; Ansley DM; Merrick PM
    Circulation; 1997 Nov; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
    Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
    Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
    Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-low dose aprotinin effects on reducing the need for blood transfusion in cardiac surgery.
    Parvizi R; Azarfarin R; Hassanzadeh S
    Saudi Med J; 2007 Jan; 28(1):49-53. PubMed ID: 17206289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
    Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
    Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.